Literature DB >> 32092593

Core-shell structured upconversion nanocrystal-dendrimer composite as a carrier for mitochondria targeting and catalase enhanced anti-cancer photodynamic therapy.

Shuang Liang1, Chunqiang Sun2, Piaoping Yang3, Ping'an Ma1, Shanshan Huang4, Ziyong Cheng1, Xifei Yu5, Jun Lin6.   

Abstract

Recently, photodynamic therapy (PDT) has been deemed to be the most promising strategy for cancer treatment. To improve the efficacy for PDT, nanocarriers are expected to target mitochondria that are vulnerable to toxic reactive oxygen species (ROS). Moreover, overcoming tumor hypoxia is also conducive to enhance the PDT efficacy. Upconversion nanoparticles (UCNPs) can convert near infrared (NIR) light to visible light, thus stimulating photosensitizers to effectively produce cytotoxic ROS and achieving a high tissue penetration depth. In this study, a multifunctional nanocarrier UCNPs@G4/Ce6/CAT-CTPP was synthesized by a novel thiol-ene and azide-acetylene click reaction route to connect the original oleic acid ligands and dendrimers. Interestingly, the constructed "hydrophobic and hydrophilic pockets" around one single upconversion nanoparticle can simultaneously load hydrophobic photosensitizer Chlorin e6 (Ce6) and hydrophilic catalase (CTA) for catalytic enhanced PDT activated by NIR laser. Also, the mitochondrial targeting molecules (3-carboxypropyl) triphenylphosphonium bromide (CTPP) were modified outside of the dendrimers to efficiently target mitochondria. Both the catalytic degradation of hydrogen peroxide (H2O2) by catalase to overcome tumor hypoxia and mitochondrial targeting greatly enhance the efficacy of PDT. More importantly, this system provides a new paradigm for designing inorganic nanocrystal core and dendrimer shell for cargo delivery.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Click-reaction; Dendrimer; Mitochondria targeting; Photodynamic therapy; Upconversion nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32092593     DOI: 10.1016/j.biomaterials.2020.119850

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

Review 1.  Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer.

Authors:  Aleksandra Benko; David Medina-Cruz; Ada Vernet-Crua; Catherine P O'Connell; Małgorzata Świętek; Hamed Barabadi; Muthupandian Saravanan; Thomas J Webster
Journal:  Cancer Drug Resist       Date:  2021-06-19

Review 2.  Recent Progress of Metal-Organic Framework-Based Photodynamic Therapy for Cancer Treatment.

Authors:  Yuyun Ye; Yifan Zhao; Yong Sun; Jie Cao
Journal:  Int J Nanomedicine       Date:  2022-05-23

Review 3.  Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine.

Authors:  Wei-Peng Li; Chia-Jui Yen; Bo-Sheng Wu; Tak-Wah Wong
Journal:  Biomedicines       Date:  2021-01-12

Review 4.  Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years.

Authors:  Xinyan Hao; Junyong Wu; DaXiong Xiang; Yongyu Yang
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

Review 5.  Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy.

Authors:  Jiangsheng Xu; James G Shamul; Elyahb Allie Kwizera; Xiaoming He
Journal:  Nanomaterials (Basel)       Date:  2022-02-23       Impact factor: 5.719

Review 6.  Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy.

Authors:  Zhihong Cheng; Yongshuang Li; Duoyi Zhao; Wei Zhao; Meng Wu; Weilin Zhang; Yan Cui; Peng Zhang; Zhiyu Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-06

Review 7.  High Drug-Loading Nanomedicines for Tumor Chemo-Photo Combination Therapy: Advances and Perspectives.

Authors:  Ya Wang; Yujie Zhang; Xiaojiang Zhang; Zhe Zhang; Junjun She; Daocheng Wu; Wei Gao
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

Review 8.  Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy.

Authors:  Sathish Sundar Dhilip Kumar; Heidi Abrahamse
Journal:  Front Chem       Date:  2022-08-15       Impact factor: 5.545

Review 9.  Bioenzyme-based nanomedicines for enhanced cancer therapy.

Authors:  Mengbin Ding; Yijing Zhang; Jingchao Li; Kanyi Pu
Journal:  Nano Converg       Date:  2022-02-04

10.  Protective Effects of Bone Marrow Mesenchymal Stem Cells (BMMSCS) Combined with Normothermic Machine Perfusion on Liver Grafts Donated After Circulatory Death via Reducing the Ferroptosis of Hepatocytes.

Authors:  Dong Sun; Liu Yang; Weiping Zheng; Huan Cao; Longlong Wu; Hongli Song
Journal:  Med Sci Monit       Date:  2021-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.